-
Overview
Date & Location
07/07/2021 – 07/25/2023, 12:00 AM CST Online
Overview
The episode discusses the thrombotic complications of COVID-19 and describes the effects of COVID-19 on the heart. It will also compare and contrast the types of myocarditis related to COVID-19.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 9
- Discuss the thrombotic complications of COVID-19
- Describe the effects of COVID-19 on the heart
- Compare and contrast types of myocarditis related to COVID-19
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
University of Texas Health Science Center at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
University of Texas Health Science Center at San Antonio designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 07/07/2021 Credits expire: 07/25/2023
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Allen Anderson, MD, FACC, FAHA
Chief, Janey & Dolph Briscoe Division of Cardiology
Director, UT/UHS Heart and Vascular Institute
Janey Briscoe Distinguished University Chair in Cardiovascular Research
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioAllen S. Anderson, MD, FACC, FAHA has just assumed his new role as Chief of the Cardiology Division and Professor of Medicine (tenure) in the Department of Medicine at the University of Texas San Antonio. Formerly, he was the Medical Director of the Center for Heart Failure in the Bluhm Cardiovascular Institute of Northwestern Medicine and Chief of the Section of Heart Failure and Transplant in the Division of Cardiology and Professor of Medicine at Northwestern Medicine. His research interests include the non-invasive assessment of heart failure and cardiac transplant patients, valvular heart disease in heart failure patients and the development of novel therapeutic approaches for advanced heart failure patients.
Dr. Anderson, a Georgia native, graduated from the Emory University School of Medicine. He completed internal medicine training, including a chief residency, at New York University/Bellevue Medical Center, followed by general cardiology fellowship at the University of Chicago and one year of advanced heart failure/transplant training at Columbia Presbyterian Medical Center in New York. He is Board Certified in Cardiovascular Diseases and Advanced Heart Failure and Cardiac Transplantation.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial and has received an honorarium from Pfizer for an antifungal symposium and has received honoraria from Medscape.
Dr. Allen S Anderson has disclosed that he is a consultant for Edwards, on the speakers bureau for Relypsa, Novartis and Pfizer and provides Research Support for Abbott (Thoratec/St. Jude).
Logins
Find
Events
Technology
Episode 8 - Let's Get Vaccinated
-
Overview
Date & Location
06/29/2021 – 06/29/2021, 12:00 AM CST Online
Overview
The episode addresses the rates of COVID vaccinations by state, in the US and worldwide. Where are we with vaccinations and are we still at risk from COVID surges. Will also identify the risks for recurring surges of COVID and list some reasons for increasing vaccination rates.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 8
- Review the rates of COVID vaccination by state, in the US, and worldwide.
- Discuss the decreasing rates of COVID
- Identify the risks for recurring surges of COVID.
- List the reasons to increase vaccination rates
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
University of Texas Health Science Center at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
University of Texas Health Science Center at San Antonio designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 06/29/2021 Credits expire: 06/29/2022
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial and has received an honorarium from Pfizer for an antifungal symposium and has received honoraria from Medscape.
Episode 7 - Long Covid (Post-Acute Sequelae of COVID (PASC))
-
Overview
Date & Location
05/19/2021 – 07/25/2023, 12:00 AM CST Online
Overview
This episode addresses the lingering symptoms that occur and remain after an episode of COVID. Common problem experienced by patients with PASC are discussed and recommendation for common symptoms are provided.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 7
- Discuss the lingering symptoms that occur and remain after an episode of COVID.
- Discuss the most common problem of PASC.
- Provide recommended therapies or modalities for chronic fatigue, anosmia, and brain fog.
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
University of Texas Health Science Center at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
University of Texas Health Science Center at San Antonio designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 05/19/2021 Credits expire: 07/25/2023
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Monica Verduzco-Gutierrez, MD
Professor and Chair
Department of Rehabilitation Medicine
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Monica Verduzco-Gutierrez is an accomplished academic Physiatrist and Professor and Chair of the Department of Rehabilitation Medicine at the Long School of Medicine at UT Health San Antonio. She previously was a Medical Director of the Brain Injury and Stroke Program at a top three US News and World Report Best Hospital for Rehabilitation.
Dr. Gutierrez grew up in South Texas, then moved to Houston where she earned her undergraduate degree at Rice University, her medical degree at Baylor College of Medicine, and completed her PM&R residency training at the Baylor College of Medicine-UT Houston Rehabilitation Alliance. She excitedly moved to San Antonio to lead the distinguished Department of Rehabilitation Medicine in 2020. Her area of clinical expertise is the care of patients with traumatic brain injury, stroke rehabilitation, and interventional spasticity management. Most recently, she has developed a Post-COVID Recovery Clinic to help those who were diagnosed with COVID-19 and suffer from various physical, cognitive, and functional difficulties.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial and has received an honorarium from Pfizer for an antifungal symposium and has received honoraria from Medscape.
Dr. Monica Verduzco-Gutierrez has no relevant disclosures. She has been a paid consultant for Merz, Allergan, Ipsen, Medtronic, and Piramal.
COVID Minutes Podcast Episode 6 - COVID treatment – One Year In
-
Overview
Date & Location
03/19/2021 – 03/19/2021, 12:00 AM CST Online
Overview
This episode reflects on the progression of COVID treatments one year in, and discusses the biggest advances in the treatment for COVID-19 over the past year. Lessons learned from the ACT2 trial study are discussed as well as lessons learned from other trials. Preliminary studies on monulpiravir, and oral antiviral drug, is also discussed.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 6
- Discuss the biggest advances in COVID-19.
- Discuss beneficial agents in preventing COVID-19.
- Discuss the role of anti-virals in the treatment of COVID-19.
- Discuss preliminary studies of monulpiravir.
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
University of Texas Health Science Center at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
University of Texas Health Science Center at San Antonio designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 03/19/2021 Credits expire: 03/19/2022
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Phil Ponce, MD
Assistant Professor of Medicine/Infectious Diseases
Joe R. and Teresa Lozano Long School of Medicine
UT Health San Antonio
Medical Director Transplant Infectious Diseases, University HealthDr. Ponce is currently an Assistant Professor of Infectious Diseases at UT Health San Antonio. His usual clinical responsibilities include serving as the Director of Transplant ID at the University Transplant Center and the Medical Director of the Kind Clinic, a nonprofit clinic focused on STI testing and treatment, HIV prevention, and HIV care. Since the advent of the COVID epidemic he has been a site co-investigator on the NIH ACTT and ACTIV clinical trials at UT Health San Antonio. He is the COVID ID liaison to the Hospital Medicine service, helping to develop the University Hospital treatment protocols, and is a regular attending on the inpatient COVID ID consult service.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial and recieves honorarium from Pfizer.
Dr. Phil Ponce has disclosed that he is NIH ACTT co-investigator and sub-investigator on the Novavax SARS-Co-V-2 vaccine trial.
Episode 5 - Monoclonal Antibodies for COVID-19
-
Overview
Date & Location
12/15/2020 – 12/15/2021, 12:00 AM CST Online
Overview
This episode describes monoclonal antibodies bamlanivimab and casirivimab/imdevimab and the FDA Emergency Use Authorization for these agents. Criteria for use, including patients who are eligible and not eligible for this therapy are discussed, and potential benefits of therapy. The Regional Infusion Center, a unique collaboration between the Regional Advisory Council, San Antonio Fire and EMS, and local hospitals, is described and discussed.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 5
- Describe the monoclonal antibodies and their potential benefit.
- List those who are eligible to recieve monoclonal antibodies for potential benefit.
- List those who are not eligible to recieve monoclonal antibodies.
- Describe the Regional Infusion Center that is a result of collaboration in San Antonio area.
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 12/15/2020 Credits expire: 12/15/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
C. J. Winckler, MD
Assistant Professor/Clinical
Deputy Medical Director, San Antonio Fire Department
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. C. J. Winckler is an Assistant Professor of Emergency Health Services at UT Health San Antonio and Deputy Medical Director for the San Antonio Fire Department / Emergency Medical Services.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Dr. C.J. Winckler does not have any relevant financial relationships to disclose.
Episode 4 - Vaccine Update
-
Overview
Date & Location
12/9/2020 – 12/9/2021, 12:00 AM CST Online
Overview
This podcast discusses the latest updates on vaccine trials to include the development processes used for the leading vaccine candidates. Strategies for the development of these vaccines is discussed and the timeline for vaccine distribution is also outlined. Finally, Dr. Taylor discusses what she believes our world will look like once vaccines are available.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 4
- Describe the vaccine development processes used for leading COVID-19 vaccine candidates.
- Compare and contrast the leading COVID-19 vaccine candidates.
- Outline the timeline for COVID-19 vaccine distribution.
- Describe what a post-vaccine world will look like in the short-term and in the long-term.
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 12/9/2020 Credits expire: 12/9/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Barbara S. Taylor, MD, MS
Associate Professor of Infectious Diseases
Assistant Dean for the MD/MPH Program
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Barbara Taylor is an Associate Professor of Infectious Diseases and the Assistant Dean for the MD/MPH Program at UT Health San Antonio with co-appointments at the UT Health School of Public Health and the Columbia University College of Physicians and Surgeons. She has disclosed that she is a principal investigator for the COVID-19 Prevention Network.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Dr. Barbara Taylor has disclosed that she is a principal investigator for the COVID-19 Prevention Network.
Episode 3 - Outpatient Management Strategies for COVID-19
-
Overview
Date & Location
11/24/2020 - 11/24/2021, 12:00AM CST Online
Overview
This is a conversation with Dr. Ruth Berggren, Professor of Medicine/Infectious Diseases and Director, Center for Medical Humanities and Ethics at UT Health San Antonio, regarding outpatient management strategies for COVID-19. General recommendations are discussed, as well as the use of monoclonal antibodies and the off-label use of supplements and medications for which there is some preliminary data.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 3
- List equipment recommended for the outpatient with COVID-19
- Discuss the role of monoclonal antibodies in the treatment of COVID-19
- List supplements and mediciations that have shown promise in the preliminary studies for coronavirus infection (off-label use).
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 11/24/2020 Credits expire: 11/24/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Ruth Berggren, MD, MACP
Professor of Medicine/Infectious Diseases
Joe R. and Teresa Lozano Long School of Medicine
Director, Center for Medical Humanities and Ethics
UT Health San AntonioDr. Berggren is a Professor of Medicine/Infectious Diseases at The Joe R. and Teresa Lozano Long School of Medicine and directs the Center for Medical Humanities & Ethics at UT Health San Antonio. In this role, she teaches ethics and professionalism while nurturing empathy and humanitarian values. The Center focuses on four areas: ethics and professionalism; global health; community service learning; and the medical humanities (literature, music and art).
Dr. Berggren arrived at UT Health San Antonio in fall 2006 after an eventful stint at New Orleans’ Charity Hospital, where she stood by her mostly uninsured patients in the HIV ward during Hurricane Katrina until all were safely evacuated six days later. She reflected on the experience in articles published in the New England Journal of Medicine and a commencement address to the Health Science Center School of Medicine. Her determination to inspire humanism in medicine and effect change through her own experiences led to her being named director of the Center for Medical Humanities & Ethics in October 2007.
The daughter of public health physicians, Dr. Berggren spent her childhood at Haiti’s Hôpital Albert Schweitzer, named for the Nobel Prize-winning physician and humanitarian known for his philosophy of reverence for life. During medical school, she was named an Albert Schweitzer Fellow and traveled to the West African nation of Gabon to work at the hospital established by Dr. Schweitzer. Her involvement in global health and ties to Haiti continue today. Following the 2010 earthquake in Haiti, Dr. Berggren was active in relief efforts along the Haitian-Dominican border. She lectured widely on these experiences and on disaster preparedness for the American College of Physicians, Centers for Disease Control, American Medical Association, Pan American Health Organization and medical schools nationwide.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Dr. Ruth Berggren has disclosed that she is a sub-investigator for the Sinai vaccine trial.
Episode 2 - Testing and Prevention Strategies
-
Overview
Date & Location
11/11/2020 - 11/11/2021, 12:00AM CST Online
Overview
This podcast discusses testing strategies and updates as well as prevention strategies for COVID-19 to include PCR testing, antigen testing and the role of antibody testing. COVID-19 infection control and lessons learned is also discussed.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 2
- Discuss PCR testing, Antigen testing, and the role of antibody testing and its advantages and disadvantages.
- Discuss hospital control measures and what has been learned from the COVID-19 pandemic
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 11/11/2020 Credits expire: 11/11/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Practices Advisory Committee and has been a consultant to San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH Adaptive COVID-19 Treatment Trial (ACTT) studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Jason Bowling, MD
Associate Professor of Medicine/Infectious Diseases
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Bowling is an Associate Professor of Medicine, Division of Infectious Diseases at the Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. He is a clinician and a healthcare epidemiologist at University Health. He is also an investigator for the Adaptive COVID-19 Treatment Trial (ACTT) conducted at University Hospital and a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health and University Hospital.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Dr. Jason Bowling has disclosed that he is an NIH ACTT co- investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial.
Episode 1: New and Emerging Therapies for COVID-19
-
Overview
Date & Location
11/8/2020 - 11/8/2021, 12:00AM CST Online
Overview
This podcast discusses new and emerging therapies for COVID-19 to include the efficacy of the antiviral remdesivir and it use in COVID-19 patients as well as other candidate treatments currently being studied for COVID-19 hospitalized patients. The potential role of monoclonal antibodies in COVID-19 treatment is also discussed.
Target Audience
This educational activity is designed to meet the educational goals of physicians and other healthcare professionals specializing in infectious diseases, family and community medicine, internal medicine, emergency medicine, and all those involved with the management of patients with coronavirus.
Learning Objectives for the Episode 1
- Discuss the efficacy of the antiviral remdesivir and when it should be used in COVID-19 patients
- List other candidate treatments being studied for the treatment of COVID-19 in hospitalized patients
- Describe the potential role of monoclonal antibodies in treating COVID-19
Program Registration Information
Registration Fees - $0.00
Continuing Medical Education Education Credit - Accreditation and Designation Statement
The Joe R. and Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
Release date: 11/8/2020 Credits expire: 11/8/2021
-
Faculty
Jan E. Patterson, MD, MS, MACP
FIDSA, FSHEA, CHCP
Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality & Lifelong Learning
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine/Infectious Diseases and Associate Dean for Quality & Lifelong Learning at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. She is clinician and a healthcare epidemiologist and has served on the Infectious Diseases Society of America Board of Directors and is Past President of the Society for Healthcare Epidemiology of America. She is a longtime infectious diseases consultant to Southwest Texas Regional Advisory Council (STRAC) and has also served on CDC’s Healthcare Infection Control Practices Advisory Committee and has been a consultant to the City of San Antonio Metro Health Department. She has been a site principal investigator for new antimicrobial agents and is currently a co-investigator for the NIH ACTT studies as outlined above and is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health SA and University Hospital.
Thomas F. Patterson, MD
Professor of Medicine/Infectious Diseases and Pathology
Division Chief, Infectious Diseases
Vice Chair for Faculty Development
Joe R. and Teresa Lozano Long School of Medicine
UT Health San AntonioDr. Patterson is a Professor of Medicine and Chief, Division of Infectious Diseases and serves as the Vice-Chair for Faculty Development in the Department of Medicine at The Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio. He is a clinician and longtime clinical investigator, particularly in the development of new antifungal drugs and in clinical trials of new antifungal compounds. He has had long-term funding from the NIH and industry for grants and contracts on drug and diagnostic development. During this COVID-19 pandemic, Dr. Patterson leads the UT Health Division of Infectious Diseases efforts in clinical management of COVID-19 care and is the site principal investigator for the Adaptive COVID-19 Treatment Trial (ACTT) conducted at University Hospital and supported by the National Institutes of Health to develop safe and effective therapies against COVID-19. He is a sub-investigator for the Novavax SARS-CoV-2 vaccine trial at UT Health SA and University Hospital.
Relevant Financial Disclosures
Dr. Jan Patterson has disclosed that she is a NIH ACTT co-investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial. She is the spouse of Dr. Thomas Patterson.
Dr. Tom Patterson has disclosed that he is a NIH ACTT investigator and sub-investigator for the Novavax SARS-CoV-2 vaccine trial. He is the spouse of Dr. Jan Patterson.
